AI assistant
Sending…
Rakon Limited — Director's Dealing 2025
Oct 28, 2025
66260_rns_2025-10-29_aae0224f-557c-422c-9fb9-10d3a700deaf.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [82 x 23] intentionally omitted <==
Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
| To NZX Limited; and | |||
|---|---|---|---|
| Name of listed issuer: | Rakon Limited | ||
| Date this disclosure made: | 28-Oct-25 | ||
| Date on which issuer listed or appointment made: | 28-Oct-25 | ||
| Director or senior manager giving disclosure | |||
| Full name: | Christopher Grant Swasbrook | ||
| Name of listed issuer: | Rakon Limited | ||
| Name of related bodycorporate(if applicable): | |||
| Position held in listed issuer: | Independent Director | ||
| Summary of relevant interest (excluding specified derivatives) | |||
| Class of quoted financial product: | Ordinary Shares | ||
| Number held in class: | 1,350,000 | ||
| Nature of relevant interest: | Power to Influence as Portfolio Manager & Director | ||
| Current registered holder: | Public Trust as Custodian for Elevation Capital Global Shares Fund | ||
| Summary of specified derivatives relevant interest (if applicable) | |||
| Type of derivative: | |||
| Class of underlyingfinancialproducts: | |||
| Details of derivative | |||
| The notional value of the derivative (if any) or the notional amount of underlying | |||
| products (if any): | |||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturitydate of the derivative (if any): | |||
| Expirydate of the derivative (if any): | |||
| Theprice specified in the terms of the derivative(if any): | |||
| Any other details needed to understand how the amount of the consideration payable | |||
| under the derivative or the value of the derivative is affected by the value of the | |||
| underlyingfinancialproducts: | |||
| For that derivative,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the | |||
| relevant interest in the derivative: | |||
| Certification | |||
| I, certify that, to the best of my knowledge and belief, the information contained in this | |||
| disclosure is correct and that I am duly authorised to make this disclosure by all | |||
| persons for whom it is made. | |||
| Signature of director or officer: | Chris Swasbrook | ||
| Date of signature: | 28-Oct-25 | ||
| or | |||
| Signature ofperson authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorised person: | |||
| Notes |
Use this form to disclose the relevant interests that a director or senior manager of a listed issuer has in quoted financial products of the listed issuer or a related body corporate or a specified derivative. The disclosure must be made within 5 trading days of—
(a) the listing of the public issuer; or
(b) the person’s appointment as a director or senior manager.
More from Rakon Limited
Delisting Announcement
2026
May 18
M&A Activity
2026
May 17
M&A Activity
2026
May 17
Major Shareholding Notification
2026
May 12
Major Shareholding Notification
2026
May 8
Major Shareholding Notification
2026
May 8
Major Shareholding Notification
2026
May 8
Major Shareholding Notification
2026
May 4
Major Shareholding Notification
2026
May 4
M&A Activity
2026
May 1